237
Participants
Start Date
April 30, 2004
Primary Completion Date
October 31, 2007
Study Completion Date
October 31, 2007
Anastrozole
1mg/Day Oral
Risedronate Sodium
35mg/week, oral
Research Site, Palm Springs
Research Site, Jacksonville
Research Site, New Orleans
Research Site, New York
Research Site, Raleigh
Research Site, Cleveland
Research Site, Pittsburgh
Research Site, Houston
Research Site, Burnaby
Research Site, Edmonton
Research Site, Montreal
Research Site, Québec
Research Site, Vancouver
Research Site, Bordeaux
Research Site, Caen
Research Site, Lyon
Research Site, Saint-Cloud
Research Site, Saint-Herblain
Research Site, Athens
Research Site, Irakleio
Research Site, Goes
Research Site, Ijssel
Research Site, Nijmegen
Research Site, The Hague
Research Site, Bloemfontain
Research Site, Cape Town
Research Site, Tygerberg
Research Site, Pamplona
Research Site, Pontevedra
Research Site, Seville
Research Site, Valencia
Research Site, Belfast
Research Site, Bolton
Research Site, Dundee
Research Site, Luton
Lead Sponsor
AstraZeneca
INDUSTRY